Benjamin Ely
Overview
Explore the profile of Benjamin Ely including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
498
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gabbay V, Ely B, Vileisis J, Petrovic Z, Cicvaric A, Asnis G, et al.
Res Sq
. 2024 Feb;
PMID: 38405791
Studies in adults have linked stress-related activation of the immune system to the manifestation of psychiatric conditions. Using a translational design, this study aimed to examine the impact of social...
2.
Liu Q, Ely B, Simkovic S, Tao A, Wolchok R, Alonso C, et al.
Brain Behav Immun Health
. 2020 Dec;
9.
PMID: 33381770
Introduction: Increased inflammation has been implicated in many psychiatric conditions across ages. We previously reported relationships between blood cytokine levels and anhedonia, the decreased capacity to experience pleasure, as well...
3.
Goldkorn A, Ely B, Tangen C, Tai Y, Xu T, Li H, et al.
Int J Cancer
. 2014 Sep;
136(8):1856-62.
PMID: 25219358
Circulating tumor cells (CTC) are promising biomarkers in metastatic castration resistant prostate cancer (mCRPC), and telomerase activity (TA) is a recognized cancer marker. Therefore, we hypothesized that CTC TA may...
4.
Goldkorn A, Ely B, Quinn D, Tangen C, Fink L, Xu T, et al.
J Clin Oncol
. 2014 Mar;
32(11):1136-42.
PMID: 24616308
Purpose: Circulating tumor cell (CTC) enumeration has not been prospectively validated in standard first-line docetaxel treatment for metastatic castration-resistant prostate cancer. We assessed the prognostic value of CTCs for overall...
5.
Lara Jr P, Ely B, Quinn D, Mack P, Tangen C, Gertz E, et al.
J Natl Cancer Inst
. 2014 Feb;
106(4):dju013.
PMID: 24565955
Background: Prior studies suggest that elevated markers of bone turnover are prognostic for poor survival in castration-resistant prostate cancer (CRPC). The predictive role of these markers relative to bone-targeted therapy...
6.
Hussain M, Tangen C, Berry D, Higano C, Crawford E, Liu G, et al.
N Engl J Med
. 2013 Apr;
368(14):1314-25.
PMID: 23550669
Background: Castration resistance occurs in most patients with metastatic hormone-sensitive prostate cancer who are receiving androgen-deprivation therapy. Replacing androgens before progression of the disease is hypothesized to prolong androgen dependence....
7.
Marshall J, Tangen C, Sakr W, Wood Jr D, Berry D, Klein E, et al.
Cancer Prev Res (Phila)
. 2011 Sep;
4(11):1761-9.
PMID: 21896650
The threat of prostate cancer and the significant and often negative impact of its treatment underscore the importance of prevention. High-grade prostatic intraepithelial neoplasia (HGPIN) has been identified as a...
8.
Tsuang D, Millard S, Ely B, Chi P, Wang K, Raskind W, et al.
PLoS One
. 2011 Jan;
5(12):e14456.
PMID: 21209939
Background: The detection of copy number variants (CNVs) and the results of CNV-disease association studies rely on how CNVs are defined, and because array-based technologies can only infer CNVs, CNV-calling...